Alternative Access in Congenital Heart Disease

Limited arterial vascular access precluded necessary transcatheter intervention in a 22-year-old woman with repaired interrupted aortic arch type B. Alternative transcaval vascular access enabled percutaneous therapy. This practice evolution is likely to benefit the growing numbers of adults with co...

Descripción completa

Detalles Bibliográficos
Autores principales: Heyden, Caitlin M., Moore, John W., Ryan, Justin R., Lederman, Robert J., El-Said, Howaida G., Ratnayaka, Kanishka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Mini-Focus Issue: Congenital Heart Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520567/
https://www.ncbi.nlm.nih.gov/pubmed/33000000
http://dx.doi.org/10.1016/j.jaccas.2020.07.040
_version_ 1783587800623349760
author Heyden, Caitlin M.
Moore, John W.
Ryan, Justin R.
Lederman, Robert J.
El-Said, Howaida G.
Ratnayaka, Kanishka
author_facet Heyden, Caitlin M.
Moore, John W.
Ryan, Justin R.
Lederman, Robert J.
El-Said, Howaida G.
Ratnayaka, Kanishka
author_sort Heyden, Caitlin M.
collection PubMed
description Limited arterial vascular access precluded necessary transcatheter intervention in a 22-year-old woman with repaired interrupted aortic arch type B. Alternative transcaval vascular access enabled percutaneous therapy. This practice evolution is likely to benefit the growing numbers of adults with congenital heart disease. (Level of Difficulty: Advanced.)
format Online
Article
Text
id pubmed-7520567
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75205672021-07-26 Alternative Access in Congenital Heart Disease Heyden, Caitlin M. Moore, John W. Ryan, Justin R. Lederman, Robert J. El-Said, Howaida G. Ratnayaka, Kanishka JACC Case Rep Mini-Focus Issue: Congenital Heart Disease Limited arterial vascular access precluded necessary transcatheter intervention in a 22-year-old woman with repaired interrupted aortic arch type B. Alternative transcaval vascular access enabled percutaneous therapy. This practice evolution is likely to benefit the growing numbers of adults with congenital heart disease. (Level of Difficulty: Advanced.) Elsevier 2020-09-15 /pmc/articles/PMC7520567/ /pubmed/33000000 http://dx.doi.org/10.1016/j.jaccas.2020.07.040 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Mini-Focus Issue: Congenital Heart Disease
Heyden, Caitlin M.
Moore, John W.
Ryan, Justin R.
Lederman, Robert J.
El-Said, Howaida G.
Ratnayaka, Kanishka
Alternative Access in Congenital Heart Disease
title Alternative Access in Congenital Heart Disease
title_full Alternative Access in Congenital Heart Disease
title_fullStr Alternative Access in Congenital Heart Disease
title_full_unstemmed Alternative Access in Congenital Heart Disease
title_short Alternative Access in Congenital Heart Disease
title_sort alternative access in congenital heart disease
topic Mini-Focus Issue: Congenital Heart Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520567/
https://www.ncbi.nlm.nih.gov/pubmed/33000000
http://dx.doi.org/10.1016/j.jaccas.2020.07.040
work_keys_str_mv AT heydencaitlinm alternativeaccessincongenitalheartdisease
AT moorejohnw alternativeaccessincongenitalheartdisease
AT ryanjustinr alternativeaccessincongenitalheartdisease
AT ledermanrobertj alternativeaccessincongenitalheartdisease
AT elsaidhowaidag alternativeaccessincongenitalheartdisease
AT ratnayakakanishka alternativeaccessincongenitalheartdisease

Ejemplares similares